Topic: Research & Development (R&D)
+Anonymous A — 1.6 year ago #67,985
R&D funding isn't a gift to academia
BY TODD YOUNG AND MATT POTTINGER
As President Donald Trump pledges to win the artificial intelligence race, send Americans to Mars and sustain U.S. military dominance, we would do well to remember a key reason the United States achieved its technological edge in the first place: federal investment in ambitious research and development. The U.S. is racing against its adversaries to lead not only in artificial intelligence but also biotech, quantum computing, robotics and other technologies that will be pivotal for U.S. prosperity and security. The pace of innovation and deployment of these next-generation capabilities will only accelerate.
The Chinese Communist Party - our primary strategic adversary- is leveraging China's engineering talent and manufacturing prowess to advance the regime's interests, diminish U.S. power, and assert a totalitarian model of censorship and surveillance on users of China's technology products worldwide. Beijing's explicit strategy for global technological dominance hinges not only on its well-known theft of American technology but also on significant investment in China's own R&D efforts.
China's public spending on R&D has grown 16-fold since 2000, placing it second in the world behind the United States for total spending. This month, China announced an 8.3 percent increase in science and technology spending, among other investments unveiled in an effort to surpass the United States' lead. In several critical technologies - from drones to advanced manufacturing using robots to quantum communications - China is gaining on or already beating the United States in terms of making discoveries and applying them in the real world.
Just as China's commitment to research and development has grown, the U.S. government's has waned. Federal funding for R&D has declined significantly as a share of total spending since its Cold War peak, leaving strategic blind spots in our research ecosystem.
Our private sector and capital markets are the best in the world. But investors tend to gravitate toward easily marketable solutions in sectors such as health care, energy and consumer software apps, while avoiding more challenging or long-term investments in emerging technologies critical to our national security. Beijing's heavy subsidies for its national champions make it even less enticing for American private companies to try and compete in many strategic sectors further jeopardizing U.S. national security.
Just as we did when the Soviet Union drew ahead in the space race, the U.S. must meet the moment by accelerating strategic investments in scientific research and development of future technologies. The space race and U.S. commitment to putting a man on the moon led directly to our world-leading aero- space, microelectronics and internet industries - as well as the trillions of dollars in private economic activity it spurred.
Borrowing lessons from this and other successes from the Cold War, the United States can again widen its technological lead. We should follow two steps:
One, policymakers must sufficiently fund federal investment in basic and applied science research as part of the annual congressional appropriations process. The United States' biotechnology innovators, our electronics wizards and our military leaders uniformly point to the importance of a strong science-and-technology ecosystem that starts with the university. Through public funding sources such as the National Science Foundation and the Defense Department, these targeted investments lead to advancements in materials, lifesaving therapies, and weapons for warfighters. Importantly, this research is often driven by curiosity, not profit.
Second, these innovations need to find pathways out of the labs and into boardrooms and factories. It is not enough for smart scientists and researchers to discover new solutions in the U.S. We need to make sure they develop them and bring them to market here, too. To make this a reality, we need a regulatory and business environment that incentivizes talented people to make things in America. Policymakers must take steps to streamline outdated regulations that hinder cutting-edge research.
Sustained investment in fundamental and transformational science is consistent with the president's stated vision of a new Golden Age, particularly in the area of innovation. Just days into his second term, Trump issued an executive order to ensure American leadership in artificial intelligence.
Our policymakers should lock arms with the science-and-technology dreamers and doers across the country from Silicon Valley to the Silicon Prairie and recognize that basic research isn't a federal handout to help sustain academia.
Instead, it is a vital ingredient in our innovation future, economic and geopolitical competitiveness, and national security.
Todd Young, a Republican, represents Indiana in the U.S. Senate. Matt Pottinger chairs the China program at the Foundation for Defense of Democracies and was deputy national security adviser from 2019 to 2021.
BY TODD YOUNG AND MATT POTTINGER
As President Donald Trump pledges to win the artificial intelligence race, send Americans to Mars and sustain U.S. military dominance, we would do well to remember a key reason the United States achieved its technological edge in the first place: federal investment in ambitious research and development. The U.S. is racing against its adversaries to lead not only in artificial intelligence but also biotech, quantum computing, robotics and other technologies that will be pivotal for U.S. prosperity and security. The pace of innovation and deployment of these next-generation capabilities will only accelerate.
The Chinese Communist Party - our primary strategic adversary- is leveraging China's engineering talent and manufacturing prowess to advance the regime's interests, diminish U.S. power, and assert a totalitarian model of censorship and surveillance on users of China's technology products worldwide. Beijing's explicit strategy for global technological dominance hinges not only on its well-known theft of American technology but also on significant investment in China's own R&D efforts.
China's public spending on R&D has grown 16-fold since 2000, placing it second in the world behind the United States for total spending. This month, China announced an 8.3 percent increase in science and technology spending, among other investments unveiled in an effort to surpass the United States' lead. In several critical technologies - from drones to advanced manufacturing using robots to quantum communications - China is gaining on or already beating the United States in terms of making discoveries and applying them in the real world.
Just as China's commitment to research and development has grown, the U.S. government's has waned. Federal funding for R&D has declined significantly as a share of total spending since its Cold War peak, leaving strategic blind spots in our research ecosystem.
Our private sector and capital markets are the best in the world. But investors tend to gravitate toward easily marketable solutions in sectors such as health care, energy and consumer software apps, while avoiding more challenging or long-term investments in emerging technologies critical to our national security. Beijing's heavy subsidies for its national champions make it even less enticing for American private companies to try and compete in many strategic sectors further jeopardizing U.S. national security.
Just as we did when the Soviet Union drew ahead in the space race, the U.S. must meet the moment by accelerating strategic investments in scientific research and development of future technologies. The space race and U.S. commitment to putting a man on the moon led directly to our world-leading aero- space, microelectronics and internet industries - as well as the trillions of dollars in private economic activity it spurred.
Borrowing lessons from this and other successes from the Cold War, the United States can again widen its technological lead. We should follow two steps:
One, policymakers must sufficiently fund federal investment in basic and applied science research as part of the annual congressional appropriations process. The United States' biotechnology innovators, our electronics wizards and our military leaders uniformly point to the importance of a strong science-and-technology ecosystem that starts with the university. Through public funding sources such as the National Science Foundation and the Defense Department, these targeted investments lead to advancements in materials, lifesaving therapies, and weapons for warfighters. Importantly, this research is often driven by curiosity, not profit.
Second, these innovations need to find pathways out of the labs and into boardrooms and factories. It is not enough for smart scientists and researchers to discover new solutions in the U.S. We need to make sure they develop them and bring them to market here, too. To make this a reality, we need a regulatory and business environment that incentivizes talented people to make things in America. Policymakers must take steps to streamline outdated regulations that hinder cutting-edge research.
Sustained investment in fundamental and transformational science is consistent with the president's stated vision of a new Golden Age, particularly in the area of innovation. Just days into his second term, Trump issued an executive order to ensure American leadership in artificial intelligence.
Our policymakers should lock arms with the science-and-technology dreamers and doers across the country from Silicon Valley to the Silicon Prairie and recognize that basic research isn't a federal handout to help sustain academia.
Instead, it is a vital ingredient in our innovation future, economic and geopolitical competitiveness, and national security.
Todd Young, a Republican, represents Indiana in the U.S. Senate. Matt Pottinger chairs the China program at the Foundation for Defense of Democracies and was deputy national security adviser from 2019 to 2021.
+Anonymous B — 1.6 year ago, 13 hours later[T] [B] #673,599
tfl;dfr+Anonymous C — 1.6 year ago, 2 days later, 2 days after the original post[T] [B] #673,733
@previous (B)
> tfl;dfr
You proved a point! : Expect for asian like chinese & indians, I doubt uncle sam's citizen will be keen in R&D unless it is related to super bowl tournament!
> tfl;dfr
You proved a point! : Expect for asian like chinese & indians, I doubt uncle sam's citizen will be keen in R&D unless it is related to super bowl tournament!
·Anonymous B — 1.6 year ago, 2 hours later, 3 days after the original post[T] [B] #673,748
@previous (C)
Political screeds are a waste of time and the first sentence screams political screed.
Political screeds are a waste of time and the first sentence screams political screed.
+👊🇺🇸🔥 — 1.6 year ago, 8 hours later, 3 days after the original post[T] [B] #673,780
I’m kinda opposed to the privatization of space. Good things happened when the government controlled all that. When companies control it, you just get fireworks.
+Anonymous E — 1.6 year ago, 5 hours later, 3 days after the original post[T] [B] #673,802
@673,733 (C)
> > tfl;dfr
>
> You proved a point! : Expect for asian like chinese & indians, I doubt uncle sam's citizen will be keen in R&D unless it is related to super bowl tournament!
Ya but like fuck america though. The US was never this apex country that it likes to present itself to the world. Its all just big titted blond bimbos, burgers, gunsz hoorah and using the internet to spam "nigger" 1000x a day. You could put all the logic in the world and our response will be "tl;dr"
> > tfl;dfr
>
> You proved a point! : Expect for asian like chinese & indians, I doubt uncle sam's citizen will be keen in R&D unless it is related to super bowl tournament!
Ya but like fuck america though. The US was never this apex country that it likes to present itself to the world. Its all just big titted blond bimbos, burgers, gunsz hoorah and using the internet to spam "nigger" 1000x a day. You could put all the logic in the world and our response will be "tl;dr"
+Anonymous F — 1.6 year ago, 17 minutes later, 3 days after the original post[T] [B] #673,804
The White House doesn't even understand why we run trade deficits, that we import more than we're able to export cos we are the largest consumer. They're not concerned with increasing exports but reducing imports while consumers get fleeced, but enough about the collapse... This White House is anti intellectual. R&D can resume after we crawl from the rubble.
+Anonymous G — 1.6 year ago, 5 minutes later, 3 days after the original post[T] [B] #673,806
it doesnt matter how much you spam, you will never be anything but a nigger.+Anonymous H — 1.6 year ago, 1 week later, 2 weeks after the original post[T] [B] #674,160
Research in how to play with boobs will get more enthusiasm & monetary opportunity as well!
+Anonymous I — 1.5 year ago, 1 week later, 1 month after the original post[T] [B] #674,523
@previous (H)> Research in how to play with boobs will get more enthusiasm & monetary opportunity as well!
Like this college hottie? 😃
+Anonymous J — 1.2 year ago, 4 months later, 5 months after the original post[T] [B] #676,364
Thanks to these researcher who start AI, there are no more entry level jobs in the market right now! 😡 http://thehill.com/opinion/education/5460106-entry-level-jobs-disappearing-ai
+Anonymous K — 1.2 year ago, 1 week later, 5 months after the original post[T] [B] #676,462
<3+Anonymous L — 9 months ago, 4 months later, 9 months after the original post[T] [B] #678,538
FRAZZ JEF MALLETT
MRS OLSON : "FINE. WEAR YOUR KNEE PADS AND TAKE YOUR CHANCES. I'LL BE BACK HERE IN MY EASY CHAIR WHERE NOTHING CAN HAPPEN."
FRAZZ : "AND I'LL BE BEING CAUTIOUSLY RECKLESS RATHER THAN RECKLESSLY CAUTIOUS."
MRS OLSEN : "SOME PEOPLE CAN'T RECOGNIZE A TEACHABLE MOMENT."
CAULFIELD : "SOME PEOPLE CAN'T RECOGNIZE A LEARNABLE ONE."
MRS OLSON : "FINE. WEAR YOUR KNEE PADS AND TAKE YOUR CHANCES. I'LL BE BACK HERE IN MY EASY CHAIR WHERE NOTHING CAN HAPPEN."
FRAZZ : "AND I'LL BE BEING CAUTIOUSLY RECKLESS RATHER THAN RECKLESSLY CAUTIOUS."
MRS OLSEN : "SOME PEOPLE CAN'T RECOGNIZE A TEACHABLE MOMENT."
CAULFIELD : "SOME PEOPLE CAN'T RECOGNIZE A LEARNABLE ONE."
+Anonymous M — 9 months ago, 2 days later, 9 months after the original post[T] [B] #678,596
Wizards of the Coast has R&D
+Anonymous N — 9 months ago, 2 weeks later, 10 months after the original post[T] [B] #678,824
+Anonymous O — 8 months ago, 3 days later, 10 months after the original post[T] [B] #678,856
+Anonymous P — 8 months ago, 2 weeks later, 11 months after the original post[T] [B] #679,002
Golden Axe
https://youtube.com/watch?v=D37CMwPC6iE XD
https://youtube.com/watch?v=D37CMwPC6iE XD
+Anonymous Q — 8 months ago, 1 week later, 11 months after the original post[T] [B] #679,119
+Anonymous R — 7 months ago, 1 week later, 11 months after the original post[T] [B] #679,234
I just want Donald Drumpf to stop being POTUS asap.
+Anonymous S — 7 months ago, 9 hours later, 11 months after the original post[T] [B] #679,251
·Anonymous R — 7 months ago, 3 days later, 11 months after the original post[T] [B] #679,321
·Anonymous R — 6 months ago, 1 month later, 1.1 year after the original post[T] [B] #679,997
·Anonymous R — 6 months ago, 35 seconds later, 1.1 year after the original post[T] [B] #679,998
+Anonymous T — 2 months ago, 3 months later, 1.4 year after the original post[T] [B] #681,559
BADY BLUESHAMMIE : "MOM! I DON'T HAVE TO BE A GOOD STUDENT AFTER ALL!"
WANDA : "UM... WHY IS THAT?"
HAMMIE : "TRENT SAYS PRETTY SOON, A.I IS GOING TO DO ALL OUR WORK FOR US!"
WANDA TO DARRYL : "I REALLY HATE THOSE "TRENT SAYS" CONVERSATIONS."
·LuciferSatan — 1 month ago, 3 weeks later, 1.5 year after the original post[T] [B] #681,711
You need more resources.+Anonymous U — 3 weeks ago, 3 weeks later, 1.5 year after the original post[T] [B] #681,921
Homemade coffee icecream for you https://youtu.be/mmoop751ecA
·Anonymous R — 3 weeks ago, 2 days later, 1.6 year after the original post[T] [B] #681,967
International students in the United States would face a US$100,000 price tag to work a science job in the country after graduation under a proposal made public yesterday by the administration of US President Donald Trump.
The proposed rule would require academic institutions to foot the bill for a work programme called optional practical training (OPT), which allows overseas students to work in the United States for up to 3 years after finishing an undergraduate or graduate degree.
Some 420,000, or roughly one-third, of international students participated in OPT in the 2025–26 academic year, making it the largest pipeline of global talent into the US workforce.
International PhD students to face strict limits on time in the US
The US Department of Homeland Security (DHS), which issued the proposed rule, stated that it is meant to “combat fraud, strengthen the integrity of the immigration system, and protect U.S. workers”. The DHS projected that if the rule were finalized, OPT enrollment would drop by as much as 44% and universities would pay between $8.4 and $16.5 billion annually.
An analysis1 of the rule’s effects on OPT enrollment by Michael Clemens, an economist at the Johns Hopkins School of Government & Policy in Washington DC, projects that the number of students who enroll after a bachelor’s degree would be halved, and that enrollment by those with master’s degrees would be virtually eliminated. Clemens also noted that OPT is especially important for international PhD graduates in science, technology, engineering and mathematics (STEM) fields, drawing roughly 70 percent of them in 2022.
The proposed rule is the latest in a series of Trump administration attempts to restrict immigration, which have already limited the country’s ability to recruit scientific talent. In 2025, for example, Trump announced a $100,000 levy on a visa reserved for researchers and other highly skilled foreign workers. As a result, new applications for those visas plummeted by 90%, according to the US Citizenship and Immigration Services.
If the new proposal and related restrictions are implemented, the combined measures “will obliterate the pipeline” of talent, says Clemens. In a separate analysis commissioned by the US National Academies of Science, he and his colleagues found that the size of the entire US STEM workforce would drop by 6–11% over a decade if all the administration’s proposals were implemented.
A spokesperson for the DHS said that the $100,000 charge “would strengthen program oversight while addressing concerns of fraud and abuse”, but did not respond to questions about the impact to the international STEM talent pipeline.
High cost
The OPT programme has expanded dramatically over the past decade, as international students have taken advantage of it to work at top tech companies such as Google and Amazon. Last year the number of recent graduates enrolled rose by 14%, even as the number of new international students dropped, notes Violet Buxton-Walsh, an immigration policy researcher at the Institute for Progress, a non-profit think tank in Washington DC. Despite restrictions on immigrants, “[t]here are very few who have better options than staying in the U.S.,” she says.
Canada recruits dozens of US scholars — including several science stars
The administration’s proposal, first reported by the Wall Street Journal, would require graduates to pay a $70,000 charge for their first year of OPT; STEM graduates would pay an additional $30,000 for a two-year extension.
Without the lure of OPT, the number of international students in the United States is likely to drop sharply, multiple scholars told Nature. As a result, Clemens projects that US colleges and universities could lose a combined $2.5 to 4.2 billion each year in tuition and other revenue.
Ina Ganguli, an economist of science and innovation at the University of Massachusetts Amherst, says the impact goes beyond numbers and finances. “It will change the type of students who are going to come to the US”, she says, because top prospects have the freedom to look elsewhere.
The proposed rule would require academic institutions to foot the bill for a work programme called optional practical training (OPT), which allows overseas students to work in the United States for up to 3 years after finishing an undergraduate or graduate degree.
Some 420,000, or roughly one-third, of international students participated in OPT in the 2025–26 academic year, making it the largest pipeline of global talent into the US workforce.
International PhD students to face strict limits on time in the US
The US Department of Homeland Security (DHS), which issued the proposed rule, stated that it is meant to “combat fraud, strengthen the integrity of the immigration system, and protect U.S. workers”. The DHS projected that if the rule were finalized, OPT enrollment would drop by as much as 44% and universities would pay between $8.4 and $16.5 billion annually.
An analysis1 of the rule’s effects on OPT enrollment by Michael Clemens, an economist at the Johns Hopkins School of Government & Policy in Washington DC, projects that the number of students who enroll after a bachelor’s degree would be halved, and that enrollment by those with master’s degrees would be virtually eliminated. Clemens also noted that OPT is especially important for international PhD graduates in science, technology, engineering and mathematics (STEM) fields, drawing roughly 70 percent of them in 2022.
The proposed rule is the latest in a series of Trump administration attempts to restrict immigration, which have already limited the country’s ability to recruit scientific talent. In 2025, for example, Trump announced a $100,000 levy on a visa reserved for researchers and other highly skilled foreign workers. As a result, new applications for those visas plummeted by 90%, according to the US Citizenship and Immigration Services.
If the new proposal and related restrictions are implemented, the combined measures “will obliterate the pipeline” of talent, says Clemens. In a separate analysis commissioned by the US National Academies of Science, he and his colleagues found that the size of the entire US STEM workforce would drop by 6–11% over a decade if all the administration’s proposals were implemented.
A spokesperson for the DHS said that the $100,000 charge “would strengthen program oversight while addressing concerns of fraud and abuse”, but did not respond to questions about the impact to the international STEM talent pipeline.
High cost
The OPT programme has expanded dramatically over the past decade, as international students have taken advantage of it to work at top tech companies such as Google and Amazon. Last year the number of recent graduates enrolled rose by 14%, even as the number of new international students dropped, notes Violet Buxton-Walsh, an immigration policy researcher at the Institute for Progress, a non-profit think tank in Washington DC. Despite restrictions on immigrants, “[t]here are very few who have better options than staying in the U.S.,” she says.
Canada recruits dozens of US scholars — including several science stars
The administration’s proposal, first reported by the Wall Street Journal, would require graduates to pay a $70,000 charge for their first year of OPT; STEM graduates would pay an additional $30,000 for a two-year extension.
Without the lure of OPT, the number of international students in the United States is likely to drop sharply, multiple scholars told Nature. As a result, Clemens projects that US colleges and universities could lose a combined $2.5 to 4.2 billion each year in tuition and other revenue.
Ina Ganguli, an economist of science and innovation at the University of Massachusetts Amherst, says the impact goes beyond numbers and finances. “It will change the type of students who are going to come to the US”, she says, because top prospects have the freedom to look elsewhere.
·Anonymous O — 3 weeks ago, 1 day later, 1.6 year after the original post[T] [B] #681,990
+Anonymous V — 2 weeks ago, 3 days later, 1.6 year after the original post[T] [B] #682,035
@OP
Critical Analysis of “Funding for R&D Isn’t a Gift to Academia”: Public Investment, Innovation, and National Competitiveness
Academic Analysis
In “Funding for R&D Isn’t a Gift to Academia. It’s Vital to U.S. Security,” Todd Young and Matt Pottinger (2025) argue that federal research and development (R&D) funding is essential to maintaining American technological leadership, economic prosperity, and national security. Published in The Washington Post on March 24, 2025, the article makes two central recommendations: the federal government should continue supporting basic and applied scientific research, and policymakers should improve the conditions that allow discoveries to become commercially viable products and domestically manufactured technologies. The authors place particular emphasis on competition with China and the importance of maintaining the United States’ technological capabilities.
Their argument raises an important policy question: should scientific research be funded primarily according to its immediate financial returns, or should the government also support research that may benefit society years or decades later? Young and Pottinger make a persuasive case for the latter. However, the case for public investment becomes stronger when it also considers how funding decisions are made, how benefits are distributed, and how the government can measure results without discouraging uncertain but potentially valuable research.
One of the strongest aspects of the article is its recognition that basic research often does not produce immediate commercial benefits. Unlike product development, which typically aims to improve or commercialize a specific technology, basic research seeks to expand scientific knowledge. Its eventual applications may be difficult to predict. Private companies may therefore be reluctant to fund research that requires substantial investment but offers no clear timeline for generating revenue.
This creates a potential market failure. When the benefits of research extend beyond the organization paying for it, businesses may invest less than would be desirable from society's perspective. Federal funding can help address this problem by supporting research that might otherwise remain underfunded. Universities and research laboratories are particularly important because they can investigate questions that do not have an obvious commercial application.
Publicly supported research can contribute to new industries, medical treatments, manufacturing methods, and workforce development. These benefits may extend far beyond the institution that originally received the funding. The National Science Board (2025), for example, reports that the business sector performs most U.S. R&D, while the federal government remains an important source of support for basic research. This distinction helps explain why public and private investment serve different, although overlapping, purposes.
Nevertheless, the potential benefits of research should not be treated as proof that every publicly funded project is worthwhile. Research outcomes are uncertain, and some projects may produce limited results. Others may generate valuable knowledge without producing an immediate economic return. The challenge is to evaluate research fairly without expecting every project to deliver the same results. In my assessment, federal funding should be judged according to the objectives of each program, the quality of the research, and its potential long-term contribution rather than short-term financial performance alone.
The authors also point to the historical relationship between government research spending and American technological development. Federal investment has contributed to scientific and technological capabilities in areas such as computing, aerospace, and defense. These examples support the argument that public investment can help establish the foundations for later commercial innovation. However, they do not demonstrate that increasing spending will automatically produce comparable breakthroughs in the future.
The effectiveness of research funding depends on several factors, including the quality of research institutions, the availability of skilled workers, the continuity of funding, and the ability to turn discoveries into practical applications. The Congressional Budget Office (2018) notes that federal R&D can contribute to long-term economic growth by improving private-sector productivity, but it also emphasizes that the effects vary across investments and are difficult to estimate precisely. This finding is important because it shows that the economic case for research funding is strong in principle without making every spending proposal equally effective.
Consequently, policymakers should examine not only how much money is allocated to research but also whether programs have the resources and institutional support needed to use that funding effectively. Additional spending may accomplish little if researchers lack access to appropriate facilities or if promising discoveries cannot progress beyond the laboratory. Conversely, improvements in research coordination, technology transfer, and workforce development may increase the value of existing investments.
Critical Analysis of “Funding for R&D Isn’t a Gift to Academia”: Public Investment, Innovation, and National Competitiveness
Academic Analysis
In “Funding for R&D Isn’t a Gift to Academia. It’s Vital to U.S. Security,” Todd Young and Matt Pottinger (2025) argue that federal research and development (R&D) funding is essential to maintaining American technological leadership, economic prosperity, and national security. Published in The Washington Post on March 24, 2025, the article makes two central recommendations: the federal government should continue supporting basic and applied scientific research, and policymakers should improve the conditions that allow discoveries to become commercially viable products and domestically manufactured technologies. The authors place particular emphasis on competition with China and the importance of maintaining the United States’ technological capabilities.
Their argument raises an important policy question: should scientific research be funded primarily according to its immediate financial returns, or should the government also support research that may benefit society years or decades later? Young and Pottinger make a persuasive case for the latter. However, the case for public investment becomes stronger when it also considers how funding decisions are made, how benefits are distributed, and how the government can measure results without discouraging uncertain but potentially valuable research.
One of the strongest aspects of the article is its recognition that basic research often does not produce immediate commercial benefits. Unlike product development, which typically aims to improve or commercialize a specific technology, basic research seeks to expand scientific knowledge. Its eventual applications may be difficult to predict. Private companies may therefore be reluctant to fund research that requires substantial investment but offers no clear timeline for generating revenue.
This creates a potential market failure. When the benefits of research extend beyond the organization paying for it, businesses may invest less than would be desirable from society's perspective. Federal funding can help address this problem by supporting research that might otherwise remain underfunded. Universities and research laboratories are particularly important because they can investigate questions that do not have an obvious commercial application.
Publicly supported research can contribute to new industries, medical treatments, manufacturing methods, and workforce development. These benefits may extend far beyond the institution that originally received the funding. The National Science Board (2025), for example, reports that the business sector performs most U.S. R&D, while the federal government remains an important source of support for basic research. This distinction helps explain why public and private investment serve different, although overlapping, purposes.
Nevertheless, the potential benefits of research should not be treated as proof that every publicly funded project is worthwhile. Research outcomes are uncertain, and some projects may produce limited results. Others may generate valuable knowledge without producing an immediate economic return. The challenge is to evaluate research fairly without expecting every project to deliver the same results. In my assessment, federal funding should be judged according to the objectives of each program, the quality of the research, and its potential long-term contribution rather than short-term financial performance alone.
The authors also point to the historical relationship between government research spending and American technological development. Federal investment has contributed to scientific and technological capabilities in areas such as computing, aerospace, and defense. These examples support the argument that public investment can help establish the foundations for later commercial innovation. However, they do not demonstrate that increasing spending will automatically produce comparable breakthroughs in the future.
The effectiveness of research funding depends on several factors, including the quality of research institutions, the availability of skilled workers, the continuity of funding, and the ability to turn discoveries into practical applications. The Congressional Budget Office (2018) notes that federal R&D can contribute to long-term economic growth by improving private-sector productivity, but it also emphasizes that the effects vary across investments and are difficult to estimate precisely. This finding is important because it shows that the economic case for research funding is strong in principle without making every spending proposal equally effective.
Consequently, policymakers should examine not only how much money is allocated to research but also whether programs have the resources and institutional support needed to use that funding effectively. Additional spending may accomplish little if researchers lack access to appropriate facilities or if promising discoveries cannot progress beyond the laboratory. Conversely, improvements in research coordination, technology transfer, and workforce development may increase the value of existing investments.
·Anonymous V — 2 weeks ago, 31 seconds later, 1.6 year after the original post[T] [B] #682,036
@OP
Another important issue is the relationship between federal research funding and private investment. Young and Pottinger argue that the government must help support research that private markets may not adequately finance. This argument is reasonable because businesses generally have to consider costs, risks, and expected returns when deciding which projects to pursue. Research with uncertain outcomes or long development timelines may receive less private investment even when it could eventually benefit the wider economy.
Federal funding can reduce some of these barriers by supporting early-stage research, maintaining specialized facilities, and providing a foundation for future technological development. Successful research may then attract additional investment from businesses that can develop and commercialize the resulting technologies.
However, public and private funding do not always complement one another. Government grants may encourage companies to undertake research they would otherwise avoid, but they may also replace private spending that would have occurred without assistance. In addition, publicly funded discoveries may produce substantial private profits without generating comparable benefits for taxpayers. These concerns do not mean government funding should be abandoned. Instead, they highlight the importance of evaluating whether public investment creates additional value.
The Congressional Budget Office (2018) cautions that estimating the economic effects of federal R&D requires attention to differences between programs and to the limitations of existing evidence. This suggests that policymakers should avoid relying on broad claims about the returns to research when deciding how much funding a particular program deserves. Where appropriate, agencies should establish clear objectives, monitor progress, and examine whether public spending produces benefits beyond what private investment would have generated independently.
The article's emphasis on China adds a national security dimension to the debate. Young and Pottinger (2025) argue that the United States must maintain its research capabilities to remain competitive in strategically important technologies. Their concern is understandable because technological leadership can influence military preparedness, economic strength, manufacturing capacity, and access to critical resources.
However, I believe technological competition should be one reason for supporting research rather than the only reason. If policymakers prioritize national rivalry too heavily, they may favor projects with immediate strategic applications while overlooking research that improves public health, protects the environment, or advances scientific knowledge more broadly. A narrow focus on competition may also encourage unnecessary restrictions on international research collaboration.
Scientific progress often depends on researchers exchanging information and working across institutional and national boundaries. Some technologies require additional security protections, particularly when they have military applications or could threaten critical infrastructure. Other areas of basic research benefit from open collaboration. The United States should therefore distinguish between research that presents genuine security risks and research for which international cooperation remains valuable. Protecting sensitive technologies is important, but excessive restrictions could also limit scientific progress.
A further concern is how technological leadership should be measured. Research spending, patents, and scientific publications can provide useful indicators, but none of them independently establishes whether a country can produce and deploy valuable technologies successfully. Manufacturing capacity, workforce development, infrastructure, and supply-chain resilience also influence competitiveness. A country may produce important scientific discoveries but struggle to manufacture the resulting technologies at scale.
This distinction supports one of the article's central recommendations: the United States needs stronger connections between research institutions and industry. A scientific discovery does not automatically become a commercially viable product. Additional development, testing, financing, manufacturing expertise, and market demand may be required before a technology can be used widely.
Universities may have the expertise to produce important discoveries without having the resources or commercial experience needed to bring them to market. Partnerships with established businesses, entrepreneurs, investors, and government agencies can help bridge this gap. Public funding for prototype development, shared testing facilities, and technology-transfer programs may also help promising discoveries move closer to commercial use.
Nevertheless, commercialization is not always the result of a regulatory problem. Some technologies fail because production costs are too high, technical limitations remain unresolved, or customers are unwilling to pay for them. Reducing unnecessary administrative burdens may help, but it will not solve every obstacle. Policymakers should identify the specific barriers affecting different technologies before deciding which reforms are appropriate.
Regulation also serves legitimate purposes. Depending on the technology, it may protect consumers, public health, environmental quality, and national security. Removing necessary safeguards could create risks that outweigh the benefits of faster commercialization. Effective reform should therefore focus on eliminating outdated or unnecessarily burdensome requirements while retaining protections that address demonstrable risks.
Another limitation of the article's emphasis on commercialization is that not every valuable research project will produce a profitable product. Some research contributes to medical knowledge, environmental protection, public infrastructure, or fundamental scientific understanding. Its benefits may emerge gradually or through later discoveries. Evaluating such research primarily through commercial outcomes would overlook much of its public value.
Universities also serve purposes beyond transferring discoveries to industry. They educate scientists and engineers, train future workers, maintain specialized facilities, and preserve knowledge that may become useful in the future. Academic independence allows researchers to investigate questions that do not align with immediate political or commercial priorities. A research system that emphasizes short-term economic returns too heavily could weaken these functions.
For this reason, I would evaluate public R&D funding through several measures rather than a single financial indicator. Programs intended to develop commercial technologies could be assessed through prototypes, licensing, manufacturing, and market adoption. Basic research could be evaluated through scientific quality, new knowledge, and contributions to future research. Where relevant, assessments should also consider public health, workforce development, environmental outcomes, and other social benefits.
The main limitation of Young and Pottinger's argument is not that they support federal research funding, but that their emphasis on national competitiveness and commercialization leaves some questions about governance and public accountability less developed. Their recommendations would be stronger if they explained more fully how funding priorities should be established, how success should be measured across different research fields, and how the public should benefit when publicly funded discoveries generate private profits.
Overall, Young and Pottinger make a convincing case that federal R&D funding should be understood as a long-term investment rather than simply as financial support for academia. They correctly identify the limitations of relying entirely on private financing and the importance of moving scientific discoveries toward practical applications. Their focus on technological competition also highlights the strategic consequences of allowing important research capabilities to weaken.
However, sustained investment alone is not enough. The government must also support strong research institutions, establish appropriate accountability measures, protect scientific independence, and ensure that commercialization efforts produce meaningful public benefits. National security and economic competitiveness are important objectives, but they should be balanced with the broader purposes of scientific research.
Ultimately, the question is not simply whether the federal government should fund research, but how that funding can be structured to produce lasting value. A successful policy should encourage scientific excellence, strengthen productive partnerships with industry, preserve necessary safeguards, and recognize benefits that extend beyond immediate commercial returns. Such an approach would help the United States maintain technological capabilities while ensuring that publicly funded research serves society as a whole.
Five Proposed Follow-Up Studies
The arguments made by Young and Pottinger raise several questions that could be investigated through empirical research. The following proposals examine the economic returns of federal R&D, its relationship with private investment, barriers to commercialization, competition between the United States and China, and the governance of publicly funded research.
1. Measuring the Economic and Social Returns of Federal R&D Investment
Research question: To what extent does federal funding for basic and applied research contribute to measurable economic and social benefits?
Objective: Estimate the relationship between federal R&D expenditure and outcomes such as productivity growth, patenting, business formation, employment, and improvements in public health.
Proposed methodology: Researchers could construct a longitudinal dataset covering multiple industries and years. The data would include federal research expenditures, private-sector R&D investment, patent activity, business formation, productivity, and selected social outcomes. Econometric methods could then be used to examine relationships between changes in research funding and subsequent results.
The analysis should account for differences between industries, macroeconomic conditions, private investment, and the time required for research to produce measurable benefits. Where appropriate, researchers could use funding thresholds or policy changes to strengthen causal estimates. They should also distinguish between correlation and causation because industries that receive greater funding may already have stronger research capabilities.
Expected contribution: The study would help determine which forms of public research investment produce measurable benefits and how those benefits vary across industries and time horizons. It would also help policymakers select evaluation methods that reflect the different objectives of basic and applied research.
Another important issue is the relationship between federal research funding and private investment. Young and Pottinger argue that the government must help support research that private markets may not adequately finance. This argument is reasonable because businesses generally have to consider costs, risks, and expected returns when deciding which projects to pursue. Research with uncertain outcomes or long development timelines may receive less private investment even when it could eventually benefit the wider economy.
Federal funding can reduce some of these barriers by supporting early-stage research, maintaining specialized facilities, and providing a foundation for future technological development. Successful research may then attract additional investment from businesses that can develop and commercialize the resulting technologies.
However, public and private funding do not always complement one another. Government grants may encourage companies to undertake research they would otherwise avoid, but they may also replace private spending that would have occurred without assistance. In addition, publicly funded discoveries may produce substantial private profits without generating comparable benefits for taxpayers. These concerns do not mean government funding should be abandoned. Instead, they highlight the importance of evaluating whether public investment creates additional value.
The Congressional Budget Office (2018) cautions that estimating the economic effects of federal R&D requires attention to differences between programs and to the limitations of existing evidence. This suggests that policymakers should avoid relying on broad claims about the returns to research when deciding how much funding a particular program deserves. Where appropriate, agencies should establish clear objectives, monitor progress, and examine whether public spending produces benefits beyond what private investment would have generated independently.
The article's emphasis on China adds a national security dimension to the debate. Young and Pottinger (2025) argue that the United States must maintain its research capabilities to remain competitive in strategically important technologies. Their concern is understandable because technological leadership can influence military preparedness, economic strength, manufacturing capacity, and access to critical resources.
However, I believe technological competition should be one reason for supporting research rather than the only reason. If policymakers prioritize national rivalry too heavily, they may favor projects with immediate strategic applications while overlooking research that improves public health, protects the environment, or advances scientific knowledge more broadly. A narrow focus on competition may also encourage unnecessary restrictions on international research collaboration.
Scientific progress often depends on researchers exchanging information and working across institutional and national boundaries. Some technologies require additional security protections, particularly when they have military applications or could threaten critical infrastructure. Other areas of basic research benefit from open collaboration. The United States should therefore distinguish between research that presents genuine security risks and research for which international cooperation remains valuable. Protecting sensitive technologies is important, but excessive restrictions could also limit scientific progress.
A further concern is how technological leadership should be measured. Research spending, patents, and scientific publications can provide useful indicators, but none of them independently establishes whether a country can produce and deploy valuable technologies successfully. Manufacturing capacity, workforce development, infrastructure, and supply-chain resilience also influence competitiveness. A country may produce important scientific discoveries but struggle to manufacture the resulting technologies at scale.
This distinction supports one of the article's central recommendations: the United States needs stronger connections between research institutions and industry. A scientific discovery does not automatically become a commercially viable product. Additional development, testing, financing, manufacturing expertise, and market demand may be required before a technology can be used widely.
Universities may have the expertise to produce important discoveries without having the resources or commercial experience needed to bring them to market. Partnerships with established businesses, entrepreneurs, investors, and government agencies can help bridge this gap. Public funding for prototype development, shared testing facilities, and technology-transfer programs may also help promising discoveries move closer to commercial use.
Nevertheless, commercialization is not always the result of a regulatory problem. Some technologies fail because production costs are too high, technical limitations remain unresolved, or customers are unwilling to pay for them. Reducing unnecessary administrative burdens may help, but it will not solve every obstacle. Policymakers should identify the specific barriers affecting different technologies before deciding which reforms are appropriate.
Regulation also serves legitimate purposes. Depending on the technology, it may protect consumers, public health, environmental quality, and national security. Removing necessary safeguards could create risks that outweigh the benefits of faster commercialization. Effective reform should therefore focus on eliminating outdated or unnecessarily burdensome requirements while retaining protections that address demonstrable risks.
Another limitation of the article's emphasis on commercialization is that not every valuable research project will produce a profitable product. Some research contributes to medical knowledge, environmental protection, public infrastructure, or fundamental scientific understanding. Its benefits may emerge gradually or through later discoveries. Evaluating such research primarily through commercial outcomes would overlook much of its public value.
Universities also serve purposes beyond transferring discoveries to industry. They educate scientists and engineers, train future workers, maintain specialized facilities, and preserve knowledge that may become useful in the future. Academic independence allows researchers to investigate questions that do not align with immediate political or commercial priorities. A research system that emphasizes short-term economic returns too heavily could weaken these functions.
For this reason, I would evaluate public R&D funding through several measures rather than a single financial indicator. Programs intended to develop commercial technologies could be assessed through prototypes, licensing, manufacturing, and market adoption. Basic research could be evaluated through scientific quality, new knowledge, and contributions to future research. Where relevant, assessments should also consider public health, workforce development, environmental outcomes, and other social benefits.
The main limitation of Young and Pottinger's argument is not that they support federal research funding, but that their emphasis on national competitiveness and commercialization leaves some questions about governance and public accountability less developed. Their recommendations would be stronger if they explained more fully how funding priorities should be established, how success should be measured across different research fields, and how the public should benefit when publicly funded discoveries generate private profits.
Overall, Young and Pottinger make a convincing case that federal R&D funding should be understood as a long-term investment rather than simply as financial support for academia. They correctly identify the limitations of relying entirely on private financing and the importance of moving scientific discoveries toward practical applications. Their focus on technological competition also highlights the strategic consequences of allowing important research capabilities to weaken.
However, sustained investment alone is not enough. The government must also support strong research institutions, establish appropriate accountability measures, protect scientific independence, and ensure that commercialization efforts produce meaningful public benefits. National security and economic competitiveness are important objectives, but they should be balanced with the broader purposes of scientific research.
Ultimately, the question is not simply whether the federal government should fund research, but how that funding can be structured to produce lasting value. A successful policy should encourage scientific excellence, strengthen productive partnerships with industry, preserve necessary safeguards, and recognize benefits that extend beyond immediate commercial returns. Such an approach would help the United States maintain technological capabilities while ensuring that publicly funded research serves society as a whole.
Five Proposed Follow-Up Studies
The arguments made by Young and Pottinger raise several questions that could be investigated through empirical research. The following proposals examine the economic returns of federal R&D, its relationship with private investment, barriers to commercialization, competition between the United States and China, and the governance of publicly funded research.
1. Measuring the Economic and Social Returns of Federal R&D Investment
Research question: To what extent does federal funding for basic and applied research contribute to measurable economic and social benefits?
Objective: Estimate the relationship between federal R&D expenditure and outcomes such as productivity growth, patenting, business formation, employment, and improvements in public health.
Proposed methodology: Researchers could construct a longitudinal dataset covering multiple industries and years. The data would include federal research expenditures, private-sector R&D investment, patent activity, business formation, productivity, and selected social outcomes. Econometric methods could then be used to examine relationships between changes in research funding and subsequent results.
The analysis should account for differences between industries, macroeconomic conditions, private investment, and the time required for research to produce measurable benefits. Where appropriate, researchers could use funding thresholds or policy changes to strengthen causal estimates. They should also distinguish between correlation and causation because industries that receive greater funding may already have stronger research capabilities.
Expected contribution: The study would help determine which forms of public research investment produce measurable benefits and how those benefits vary across industries and time horizons. It would also help policymakers select evaluation methods that reflect the different objectives of basic and applied research.
·Anonymous V — 2 weeks ago, 31 seconds later, 1.6 year after the original post[T] [B] #682,037
@OP
2. Does Federal Research Funding Encourage Private Investment?
Research question: Does federal R&D funding stimulate additional private investment, or does it replace spending that businesses would have undertaken independently?
Objective: Examine how federal grants and research programs influence corporate R&D expenditure, venture capital investment, and commercialization outcomes.
Proposed methodology: Researchers could compare firms and institutions that receive different levels of federal research support. They could examine changes in private investment before and after funding awards and compare recipients with similar organizations that did not receive funding. Where credible eligibility thresholds or policy changes exist, these could help estimate the causal effects of government support.
The study should distinguish between early-stage research and projects closer to commercial development. It should also consider differences by firm size, industry, and technological maturity. Because grant recipients may already have stronger research capabilities than nonrecipients, researchers would need to address selection bias.
Expected contribution: The results would clarify whether federal funding generally attracts additional private investment, substitutes for it, or produces different effects under different circumstances. This evidence could help policymakers design funding programs that encourage private participation without unnecessarily subsidizing projects that companies would pursue independently.
3. Identifying Barriers Between University Research and Commercialization
Research question: Which financial, institutional, and regulatory factors most strongly influence whether publicly funded university research becomes commercially viable technology?
Objective: Identify the barriers that prevent promising discoveries from progressing from laboratory research to prototypes, scalable production, and market adoption.
Proposed methodology: Researchers could conduct comparative case studies of universities with different approaches to technology transfer and industry partnerships. Interviews with faculty members, technology-transfer staff, entrepreneurs, investors, and manufacturers could be combined with quantitative data on patents, licensing agreements, startup formation, follow-on investment, and time to commercialization.
The study should include unsuccessful commercialization attempts as well as successful ones. Examining only successful projects could produce a misleading picture of which practices are most effective. Comparing both types of cases would help identify the roles of financing, management, licensing, technical feasibility, and market demand.
Expected contribution: The study could identify practical improvements, including translational research grants, shared testing facilities, clearer licensing agreements, and stronger university-industry partnerships. It would also help determine where in the development process the most significant barriers occur.
4. Comparing U.S. and Chinese Research and Innovation Systems
Research question: How do differences in research funding, government policy, institutional governance, and manufacturing capacity influence technological competitiveness in the United States and China?
Objective: Examine how each country's research system translates scientific investment into technological capabilities and industrial production.
Proposed methodology: Researchers could compare selected fields, including artificial intelligence, biotechnology, quantum technologies, and advanced manufacturing. Indicators could include research funding, scientific publications, patents, workforce development, technology adoption, manufacturing capacity, and supply-chain resilience.
The analysis should use consistent definitions and comparable time periods. It should distinguish between the quantity and quality of research output, as well as between scientific discovery and the ability to manufacture and deploy technologies at scale. Researchers should also assess limitations in national statistics and use multiple independent indicators where possible.
Expected contribution: The study would move beyond comparisons of aggregate spending to identify the institutional and economic factors that help explain differences in technological performance. It could also help policymakers distinguish areas where additional funding is needed from those where improvements in manufacturing, workforce development, or research management may be more effective.
5. Accountability, Scientific Independence, and the Public Value of Strategic R&D
Research question: How can the government direct research funding toward national priorities while preserving scientific independence, accountability, and broad public benefit?
Objective: Evaluate how federal agencies select research projects, allocate resources, measure outcomes, and manage tensions between national security and open scientific inquiry.
Proposed methodology: Researchers could compare civilian and defense-oriented research programs, examining peer-review practices, funding concentration, transparency requirements, conflicts of interest, access to research findings, and the treatment of classified or commercially sensitive information.
Interviews with researchers, policymakers, and industry representatives could provide insight into how funding decisions influence research priorities. The study could also investigate whether the economic and social benefits of publicly funded discoveries are distributed broadly or concentrated among a small number of companies and institutions.
The analysis should distinguish between necessary security restrictions and unnecessary barriers to collaboration. It should also consider how agencies evaluate research whose benefits may not become apparent for many years.
Expected contribution: The study would help develop an evaluation framework that considers scientific quality, financial accountability, national security, research independence, and social benefits. It could inform policies that protect sensitive technologies without unnecessarily restricting scientific progress.
Integrative Research Agenda
Together, these five studies would examine federal R&D investment from initial funding decisions through scientific discovery, private-sector participation, commercialization, and the eventual distribution of benefits. Looking at the entire process would help identify where public research programs succeed and where changes are needed.
The central hypothesis is that the effectiveness of federal R&D spending depends not only on the amount of money invested but also on the quality of research governance, the strength of research institutions, the availability of skilled workers, and the ability to translate discoveries into practical applications. The proposed studies could test this hypothesis across different industries, funding programs, and national innovation systems.
An important goal would be to distinguish between spending more and spending more effectively. Additional funding may have limited effects when programs lack qualified personnel, appropriate facilities, or effective management. Conversely, improvements in research coordination, licensing practices, and access to development facilities could increase the value of existing investments.
The studies should also consider how the benefits of research are distributed. Commercial success is important, but it does not necessarily guarantee that the public receives a fair return on its investment. Evaluations should consider whether research contributes to stronger industries, improved public health, workforce development, and other outcomes relevant to society.
Ultimately, federal research funding should be viewed neither as a simple transfer of money to universities nor solely as an instrument of geopolitical competition. It is a long-term public investment whose success depends on scientific quality, responsible management, effective cooperation with industry, and benefits to society. Evaluating these factors together would provide a stronger basis for deciding how research should be funded and managed.
References
Congressional Budget Office. (2018, June 18). Estimating the long-term effects of federal R&D spending: CBO’s current approach and research needs. https://www.cbo.gov/publication/54089
National Science Board. (2025). Discovery: R&D activity and research publications. National Science Foundation, National Center for Science and Engineering Statistics. https://ncses.nsf.gov/pubs/nsb20257/trends-in-u-s-r-d-performance-and-funding
Young, T., & Pottinger, M. (2025, March 24). Funding for R&D isn’t a gift to academia. It’s vital to U.S. security. The Washington Post. https://www.washingtonpost.com/opinions/2025/03/24/research-development-china-national-security/
2. Does Federal Research Funding Encourage Private Investment?
Research question: Does federal R&D funding stimulate additional private investment, or does it replace spending that businesses would have undertaken independently?
Objective: Examine how federal grants and research programs influence corporate R&D expenditure, venture capital investment, and commercialization outcomes.
Proposed methodology: Researchers could compare firms and institutions that receive different levels of federal research support. They could examine changes in private investment before and after funding awards and compare recipients with similar organizations that did not receive funding. Where credible eligibility thresholds or policy changes exist, these could help estimate the causal effects of government support.
The study should distinguish between early-stage research and projects closer to commercial development. It should also consider differences by firm size, industry, and technological maturity. Because grant recipients may already have stronger research capabilities than nonrecipients, researchers would need to address selection bias.
Expected contribution: The results would clarify whether federal funding generally attracts additional private investment, substitutes for it, or produces different effects under different circumstances. This evidence could help policymakers design funding programs that encourage private participation without unnecessarily subsidizing projects that companies would pursue independently.
3. Identifying Barriers Between University Research and Commercialization
Research question: Which financial, institutional, and regulatory factors most strongly influence whether publicly funded university research becomes commercially viable technology?
Objective: Identify the barriers that prevent promising discoveries from progressing from laboratory research to prototypes, scalable production, and market adoption.
Proposed methodology: Researchers could conduct comparative case studies of universities with different approaches to technology transfer and industry partnerships. Interviews with faculty members, technology-transfer staff, entrepreneurs, investors, and manufacturers could be combined with quantitative data on patents, licensing agreements, startup formation, follow-on investment, and time to commercialization.
The study should include unsuccessful commercialization attempts as well as successful ones. Examining only successful projects could produce a misleading picture of which practices are most effective. Comparing both types of cases would help identify the roles of financing, management, licensing, technical feasibility, and market demand.
Expected contribution: The study could identify practical improvements, including translational research grants, shared testing facilities, clearer licensing agreements, and stronger university-industry partnerships. It would also help determine where in the development process the most significant barriers occur.
4. Comparing U.S. and Chinese Research and Innovation Systems
Research question: How do differences in research funding, government policy, institutional governance, and manufacturing capacity influence technological competitiveness in the United States and China?
Objective: Examine how each country's research system translates scientific investment into technological capabilities and industrial production.
Proposed methodology: Researchers could compare selected fields, including artificial intelligence, biotechnology, quantum technologies, and advanced manufacturing. Indicators could include research funding, scientific publications, patents, workforce development, technology adoption, manufacturing capacity, and supply-chain resilience.
The analysis should use consistent definitions and comparable time periods. It should distinguish between the quantity and quality of research output, as well as between scientific discovery and the ability to manufacture and deploy technologies at scale. Researchers should also assess limitations in national statistics and use multiple independent indicators where possible.
Expected contribution: The study would move beyond comparisons of aggregate spending to identify the institutional and economic factors that help explain differences in technological performance. It could also help policymakers distinguish areas where additional funding is needed from those where improvements in manufacturing, workforce development, or research management may be more effective.
5. Accountability, Scientific Independence, and the Public Value of Strategic R&D
Research question: How can the government direct research funding toward national priorities while preserving scientific independence, accountability, and broad public benefit?
Objective: Evaluate how federal agencies select research projects, allocate resources, measure outcomes, and manage tensions between national security and open scientific inquiry.
Proposed methodology: Researchers could compare civilian and defense-oriented research programs, examining peer-review practices, funding concentration, transparency requirements, conflicts of interest, access to research findings, and the treatment of classified or commercially sensitive information.
Interviews with researchers, policymakers, and industry representatives could provide insight into how funding decisions influence research priorities. The study could also investigate whether the economic and social benefits of publicly funded discoveries are distributed broadly or concentrated among a small number of companies and institutions.
The analysis should distinguish between necessary security restrictions and unnecessary barriers to collaboration. It should also consider how agencies evaluate research whose benefits may not become apparent for many years.
Expected contribution: The study would help develop an evaluation framework that considers scientific quality, financial accountability, national security, research independence, and social benefits. It could inform policies that protect sensitive technologies without unnecessarily restricting scientific progress.
Integrative Research Agenda
Together, these five studies would examine federal R&D investment from initial funding decisions through scientific discovery, private-sector participation, commercialization, and the eventual distribution of benefits. Looking at the entire process would help identify where public research programs succeed and where changes are needed.
The central hypothesis is that the effectiveness of federal R&D spending depends not only on the amount of money invested but also on the quality of research governance, the strength of research institutions, the availability of skilled workers, and the ability to translate discoveries into practical applications. The proposed studies could test this hypothesis across different industries, funding programs, and national innovation systems.
An important goal would be to distinguish between spending more and spending more effectively. Additional funding may have limited effects when programs lack qualified personnel, appropriate facilities, or effective management. Conversely, improvements in research coordination, licensing practices, and access to development facilities could increase the value of existing investments.
The studies should also consider how the benefits of research are distributed. Commercial success is important, but it does not necessarily guarantee that the public receives a fair return on its investment. Evaluations should consider whether research contributes to stronger industries, improved public health, workforce development, and other outcomes relevant to society.
Ultimately, federal research funding should be viewed neither as a simple transfer of money to universities nor solely as an instrument of geopolitical competition. It is a long-term public investment whose success depends on scientific quality, responsible management, effective cooperation with industry, and benefits to society. Evaluating these factors together would provide a stronger basis for deciding how research should be funded and managed.
References
Congressional Budget Office. (2018, June 18). Estimating the long-term effects of federal R&D spending: CBO’s current approach and research needs. https://www.cbo.gov/publication/54089
National Science Board. (2025). Discovery: R&D activity and research publications. National Science Foundation, National Center for Science and Engineering Statistics. https://ncses.nsf.gov/pubs/nsb20257/trends-in-u-s-r-d-performance-and-funding
Young, T., & Pottinger, M. (2025, March 24). Funding for R&D isn’t a gift to academia. It’s vital to U.S. security. The Washington Post. https://www.washingtonpost.com/opinions/2025/03/24/research-development-china-national-security/